This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Hisashi Hayashida: Innovator in Antiallergic Agents
Introduction
Hisashi Hayashida is a prominent inventor based in Chuo-ku, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as CRTH2 antagonists. His work is particularly relevant for treating various allergic disorders.
Latest Patents
Hayashida holds a patent for "Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents." This invention relates to a novel compound or a salt thereof, which is beneficial as a CRTH2 antagonist. It is especially useful as a medicament for disorders involving eosinophils, such as asthma, allergic rhinitis, allergic dermatitis, conjunctival inflammation, hives, eosinophilic bronchitis, food allergies, inflammation of the nasal sinuses, multiple sclerosis, angiitis, and chronic obstructive pulmonary disease (COPD).
Career Highlights
Hayashida is currently associated with Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work has led to advancements in treatments for allergic conditions, showcasing his commitment to improving patient outcomes.
Collaborations
He has collaborated with notable colleagues, including Tadashi Terasaka and Tatsuya Zenkoh, to further enhance the research and development of new therapeutic agents.
Conclusion
Hisashi Hayashida's contributions to the field of antiallergic agents highlight his role as a key innovator in medicinal chemistry. His patent for polycyclic acid compounds demonstrates his dedication to addressing significant health challenges.